Human Growth Hormone Market Research Report 2020-2025 | imarcgroup
According to the IMARC Group, the global human growth hormone market to register a CAGR of around 6% during 2020-2025.
Human growth hormone, also known as somatotropin or HGH, is a peptide hormone that regulates growth, reproduction, regeneration, repair and metabolism of cells. This hormone is secreted by the pituitary gland to stimulate growth in children and adults. The deficiency of HGH can be treated by administering recombinant HGH by subcutaneous injections.
Global Human Growth Hormone Market Trends:
The rising awareness regarding the efficacy of HGH in the treatment of various conditions represents one of the leading market drivers. For instance, HGH helps in controlling body composition and fluids, sugar and fat metabolism, muscle and bone growth, and recovering from injury among patients suffering from adult GH deficiency. Besides this, the increasing government initiatives to create awareness regarding the GH deficiencies and treatment acts as another significant driver. Moreover, the extensive investment in the research and development (R&D) activities for developing recombinant human growth hormones (rHGH) with fewer side effects and prolonged efficacy is also expected to provide a positive impact on the market in the upcoming years.
Request for free pdf sample copy @ https://www.imarcgroup.com/human-growth-hormone-market/requestsample
Note: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Human Growth Hormone Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast
6 Market Breakup by Application
6.1 Growth Hormone (GH) Deficiency
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Market Types
6.1.2.2 Market Types
6.1.3 Market Forecast
6.2 Turner Syndrome
6.2.1 Market Trends
6.2.1 Market Forecast
6.3 Idiopathic Short Stature (ISS)
6.3.1 Market Trends
6.3.1 Market Forecast
6.4 Prader-Willi Syndrome (PWS)
6.4.1 Market Trends
6.4.1 Market Forecast
6.5 Small for Gestational Age
6.5.1 Market Trends
6.5.1 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.1 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Pharmacy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Intravenous
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Intramuscular
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Subcutaneous
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Oral
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Eli Lilly and Company (NYSE: LLY)
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 EMD Serono Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 F. Hoffmann-La Roche AG
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 SWOT Analysis
13.3.4 Ferring B.V.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.5 Genentech Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 SWOT Analysis
13.3.6 Ipsen
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.7 Merck KGaA
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.8 Novartis AG (SWX: NOVN)
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 Novo Nordisk (CPH: NOVO-B)
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.10 Pfizer Inc. (NYSE: PFE)
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Sandoz
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
Do You Have Any Query or Specific Requirement? Ask to Our Industry Expert https://www.imarcgroup.com/request?type=report&id=2052&flag=C
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US: IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
